Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details

Email this article to a friend

Which is the best lipid-modifying strategy in metabolic syndrome and diabetes: fibrates, statins or both?

Alexander Tenenbaum email and Enrique Z Fisman email

Cardiovascular Diabetology 2004, 3:10doi:10.1186/1475-2840-3-10

Your name*
Your email address*
Recipient's email address*
(multiple email addresses should be separated with commas)
Email format
Please type your message into the box below:
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.